Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Influenza B virus (Flu D) HE Protein, C-His

Catalog #:   YVV33801 Specific References (46) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: A0A088CKZ5
Protein length: Asp80-Tyr400
Overview

Catalog No.

YVV33801

Expression system

E. coli

Species

Influenza D virus (D/bovine/Shandong/Y217/2014)

Protein length

Asp80-Tyr400

Predicted molecular weight

36.20 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

A0A088CKZ5

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Hemagglutinin-esterase-fusion glycoprotein, 3.1.1.53, HE

Data Image
References

USP1 inhibits influenza A and B virus replication in MDCK cells by mediating RIG-I deubiquitination., PMID:40369332

Unique immune and other responses of human nasal epithelial cells infected with H5N1 avian influenza virus compared to seasonal human influenza A and B viruses., PMID:40126073

Space-coded microchip for multiplexed respiratory virus detection via CRISPR-Cas12a and RPA., PMID:40024134

Seasonal influenza vaccines: Variability of immune responses to B lineage viruses., PMID:39552079

Influenza neuraminidase mutations and resistance to neuraminidase inhibitors., PMID:39530458

Comparison of Two High-Dose Versus Two Standard-Dose Influenza Vaccines in Adult Allogeneic Hematopoietic Cell Transplant Recipients., PMID:39219510

Anti-influenza virus activity of the REV-ERBα agonist SR9009 and related analogues., PMID:36122620

CD8+ T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph., PMID:34006841

Acute Cardiac Injury in Coronavirus Disease 2019 and Other Viral Infections-A Systematic Review and Meta-Analysis., PMID:33870918

Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective., PMID:32976769

Broadly protective human antibodies that target the active site of influenza virus neuraminidase., PMID:31649200

Secukinumab does not impair the immunogenic response to the influenza vaccine in patients., PMID:31565246

Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza., PMID:31454654

Anti-Influenza A Viral Butenolide from Streptomyces sp. Smu03 Inhabiting the Intestine of Elephas maximus., PMID:29976861

Case report - atypical hemolytic uremic syndrome triggered by influenza B., PMID:28320387

Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays., PMID:27870895

Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B., PMID:27222326

Production of Influenza Virus HA1 Harboring Native-Like Epitopes by Pichia pastoris., PMID:27040529

A "building block" approach to the new influenza A virus entry inhibitors with reduced cellular toxicities., PMID:26952867

The crystal structure of the PB2 cap-binding domain of influenza B virus reveals a novel cap recognition mechanism., PMID:25691568

Repetitive fulminant influenza myocarditis requiring the use of circulatory assist devices., PMID:24429449

A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains., PMID:24140051

[Applicability of a sensitive duplex real-time PCR assay for identifying B/Yamagata and B/Victoria lineages of influenza virus]., PMID:23547465

Preparation and characterization of egg yolk immunoglobulin Y specific to influenza B virus., PMID:22127067

Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits., PMID:21645575

[Clinical study on cross-infection of mycoplasma pneumoniae and other viruses in children]., PMID:20718360

Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences., PMID:20621113

[Evaluation on the safety and immunogenicity of split influenza virus vaccine]., PMID:20084888

[Virological surveillance and molecular characteristics of influenza B viruses in Hebei Province during 2004-2008]., PMID:20077671

Multiplex assay for simultaneously typing and subtyping influenza viruses by use of an electronic microarray., PMID:19073867

Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins., PMID:19007587

[Antigenic and genetic study of influenza virus circulated in China in 2006]., PMID:18322584

A case of fulminant type 1 diabetes mellitus after influenza B infection., PMID:18177974

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects., PMID:17913310

Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine., PMID:17259871

[Antigenic and genetic study of influenza virus B circulated in China in 2004-2005]., PMID:16816852

[Screening for new binding proteins which interact with BM2 of influenza B virus with yeast two-hybrid system]., PMID:16027793

[Safety and immunogenicity of split vaccines of influenza viruses]., PMID:15640848

Characterization of HeLa cells persistently infected with influenza virus B/Lee/40 with respect to telomerase activity and apoptosis., PMID:14555852

[Antigenic and genetic characterizations of Victoria like strain of influenza B viruses isolated in China in 2001]., PMID:12870010

Superoxide anion production by granulocytes incubated with HeLa 229 cells persistently infected with influenza virus B/Lee/40., PMID:12145537

Origin and evolution of influenza virus hemagglutinin genes., PMID:11919291

Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature., PMID:10438823

[Influenza virus genome structure and encoded proteins]., PMID:9360369

[Aetiologic study on the outbreaks of influenza-like disease in Shenzhen]., PMID:15619828

Sickle cell disease with complicated influenza B virus infection., PMID:1608065

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Influenza B virus (Flu D) HE Protein, C-His [YVV33801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only